现在是加快建设当地疫苗佐剂生产能力的时候了。

Q2 Medicine

Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2017-12-01 Epub Date: 2017-10-09 DOI:10.1177/2051013617733259

Christopher B Fox

{"title":"现在是加快建设当地疫苗佐剂生产能力的时候了。","authors":"Christopher B Fox","doi":"10.1177/2051013617733259","DOIUrl":null,"url":null,"abstract":"Recent accomplishments in vaccine adjuvant development are enabling new vaccines for previously intractable diseases, increased immunity in immunocompromised populations and greater global pandemic preparedness.1,2 To ensure that the potential benefits of vaccine adjuvant technology are widely accessible, it is essential that adjuvant molecules and formulations, as well as the know-how to manufacture and clinically evaluate them, are made available to developing country manufacturers.","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2051013617733259","citationCount":"5","resultStr":"{\"title\":\"It is time to accelerate building local vaccine adjuvant manufacturing capacity.\",\"authors\":\"Christopher B Fox\",\"doi\":\"10.1177/2051013617733259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recent accomplishments in vaccine adjuvant development are enabling new vaccines for previously intractable diseases, increased immunity in immunocompromised populations and greater global pandemic preparedness.1,2 To ensure that the potential benefits of vaccine adjuvant technology are widely accessible, it is essential that adjuvant molecules and formulations, as well as the know-how to manufacture and clinically evaluate them, are made available to developing country manufacturers.\",\"PeriodicalId\":33285,\"journal\":{\"name\":\"Therapeutic Advances in Vaccines and Immunotherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/2051013617733259\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Vaccines and Immunotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/2051013617733259\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/10/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Vaccines and Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2051013617733259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/10/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 5

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

It is time to accelerate building local vaccine adjuvant manufacturing capacity.

Recent accomplishments in vaccine adjuvant development are enabling new vaccines for previously intractable diseases, increased immunity in immunocompromised populations and greater global pandemic preparedness.1,2 To ensure that the potential benefits of vaccine adjuvant technology are widely accessible, it is essential that adjuvant molecules and formulations, as well as the know-how to manufacture and clinically evaluate them, are made available to developing country manufacturers.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Therapeutic Advances in Vaccines and Immunotherapy Medicine-Pharmacology (medical)

CiteScore

5.10

自引率

0.00%

发文量

审稿时长

8 weeks